Non-Alcoholic Fatty Liver Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are scheduled for a liver biopsy, or who had a liver biopsy between 1 and 6 months ago (for those with early-stage liver scarring), where the biopsy relates to suspected liver scarring caused by a fatty liver condition (NAFLD, NAFL, NASH, MASLD, or MASH)
- People who have a FIB-4 score on record (a blood test result used to assess liver health)
- People who have a FibroScan result on record (a non-invasive scan result that measures liver stiffness)
- People who have signed a written consent form to participate
- People aged 18 to 75 years old at the time their blood sample is taken
- People with a Body Mass Index (BMI) of 45 or below (a measure of body weight relative to height)
Who may not be able to join:
- People who are currently in legal detention or receiving involuntary psychiatric care
- People who are pregnant or currently breastfeeding (based on self-report)
- People whose liver condition is caused by something other than fatty liver disease — for example, alcohol-related liver disease, viral hepatitis, drug-induced liver injury, a genetic liver condition, autoimmune hepatitis, HIV, Wilson's disease, haemochromatosis, alpha-1 antitrypsin deficiency, primary biliary cirrhosis, or primary sclerosing cholangitis
- People who have or have had any type of cancer, unless that cancer has been in full remission for at least 5 years
- People who have previously had a liver transplant
- People who have another serious medical condition that is unstable or untreated — including conditions affecting the immune system, blood, hormones, digestive system, nervous system, or mental health (note: well-controlled conditions may still be permitted — confirm with trial site)
- People who report drinking more than 30 grams of alcohol per day (for men) or more than 20 grams per day (for women)
- People who have had a heart attack within the past 6 months
- People who are unable to have a liver biopsy or unable to provide a blood sample while fasting
- People with early-stage liver scarring (F0–F2) who are being recalled for the study, if their body weight has changed by more than 5% since their original biopsy
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +4915254994070
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Identification of Significant Fibrosis (≥F2); Identification of Advanced Fibrosis (≥F3)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.